Showing results (321-330 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986C-H Köhne, E van Cutsem, J Wils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015C-H Köhne, J De Greve, J T Hartmann, et al.
The Journal of Pathology|June 21, 2008
Stem cell factor as a novel diagnostic marker for early malignant germ cellsH Stoop, F Honecker, G J M van de Geijn, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|October 2, 2014
A novel approach for discovering human behavior patterns using unsupervised methodsJu Wang, J Bauer, M Becker, et al.
Leukemia|March 5, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|August 9, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|April 18, 2008
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myelomaG Schilling, T Hansen, A Shimoni, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study groupK Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)M Janning, J Süptitz, C Albers-Leischner, et al.
Pageof 34